Ketamine Completed Phase 1 Trials for Depression Treatment

IndicationsStatusPurposePhase
CompletedTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT02289248Cognitive Behavioral Therapy in Prolonging the Antidepressant Effects of Intravenous Ketamine